Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Vesiculobullous

Explore clinical trials studying Skin Diseases, Vesiculobullous. Study availability and eligibility vary by location and protocol.

235 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Vesiculobullous trial results

Completed

Short Term Observational Study in DEB Patients

NCT02178969

Conditions
Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Ann and Robert H Lurie Childrens Hospital of Chicago Chicago, Illinois, United States
  • Columbia University Medical Center New York, United States
  • Cincinnati Childrens Hospital Medical Center Cincinnati, Ohio, United States
  • Premier Specialists Pty Ltd Kogarah, Australia
View Trial Details
Completed

A Study to Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus

NCT03334058

Conditions
Autoimmune Diseases, Immune System Diseases, Pemphigus, +5 more
Locations
  • University of Lübeck and UKSH, Department of Dermatology and Lübeck Institute of Experimental Dermatology Lübeck, Germany
  • Clinic of Dermatology and Allergology - Philipps University Marburg Marburg, Germany
  • University of Debrecen Medical Center Department of Dermatology Debrecen, Hungary
  • University of Pécs Clinical Center , Department of Dermatology, Venerology and Oncodermatology Pécs, Hungary
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV)

NCT02383589

Conditions
Autoimmune Diseases, Immune System Diseases, Pemphigus, +4 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • University of Arizona Medical Research Office Tucson, Arizona, United States
  • UC Davis Department of Dermatology Sacramento, California, United States
  • Univ of Calif-San Francisco San Francisco, California, United States
View all 68 locations
View Trial Details
Completed

Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex

NCT03389308

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epidermolysis Bullosa, +7 more
Locations
  • Ann and Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • University of North Carolina (UNC) - Chapel Hill Chapel Hill, North Carolina, United States
  • Children's Hospital of San Antonio San Antonio, Texas, United States
View Trial Details

Related conditions